Roundview Capital’s Idexx Laboratories IDXX Stock Holding History

Roundview Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$246K	Buy	437 +2	+0.5%	+$1.28K	0.02%	317
2025 Q4	$294K	Buy	+435	New	+$296K	0.02%	292
2024 Q4	–	Sell	-3,265	Closed	-$1.65M	–	338
2024 Q3	$1.65M	Buy	3,265 +35	+1%	+$17K	0.12%	160
2024 Q2	$1.57M	Buy	3,230 +35	+1%	+$17.6K	0.12%	160
2024 Q1	$1.73M	Buy	3,195 +11	+0.3%	+$6.01K	0.14%	146
2023 Q4	$1.77M	Buy	+3,184	New	+$1.49M	0.16%	126
2022 Q1	–	Sell	-1,175	Closed	-$774K	–	303
2021 Q4	$774K	Buy	+1,175	New	+$738K	0.08%	213

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Roundview Capital's IDXX Position: Q1 2026 in Review

Roundview Capital increased its Idexx Laboratories (IDXX) stake by 0.46% in Q1 2026, buying an estimated $1.28K and bringing the position to 437 shares worth $246K. The position accounts for 0.02% of the portfolio, ranked #317.

Roundview Capital first reported a position in IDXX in Q4 2021 and has held it in 7 quarters since. The position peaked at $1.77M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Roundview Capital held 437 shares of Idexx Laboratories worth $246K as of Q1 2026.
Roundview Capital bought 2 Idexx Laboratories shares in Q1 2026, an estimated $1.28K.
Idexx Laboratories made up 0.02% of Roundview Capital's portfolio in Q1 2026, its #317 holding.
Roundview Capital first reported a position in Idexx Laboratories in Q4 2021 and has held it in 7 quarters since.
Roundview Capital's Idexx Laboratories position peaked at $1.77M in Q4 2023.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.